DE3683266D1 - Antibiotikum a 40926 mannosyl aglycon. - Google Patents

Antibiotikum a 40926 mannosyl aglycon.

Info

Publication number
DE3683266D1
DE3683266D1 DE8686117453T DE3683266T DE3683266D1 DE 3683266 D1 DE3683266 D1 DE 3683266D1 DE 8686117453 T DE8686117453 T DE 8686117453T DE 3683266 T DE3683266 T DE 3683266T DE 3683266 D1 DE3683266 D1 DE 3683266D1
Authority
DE
Germany
Prior art keywords
antibiotic
mannosyl aglycon
aglycon
mannosyl
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686117453T
Other languages
English (en)
Inventor
Enrico Selva
Pietro Ferrari
Beth P Goldstein
Giovanni Cassani
Francesco Parenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Application granted granted Critical
Publication of DE3683266D1 publication Critical patent/DE3683266D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
DE8686117453T 1985-12-30 1986-12-15 Antibiotikum a 40926 mannosyl aglycon. Expired - Fee Related DE3683266D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858531846A GB8531846D0 (en) 1985-12-30 1985-12-30 Antibiotic a 40926 mannosyl aglycon

Publications (1)

Publication Number Publication Date
DE3683266D1 true DE3683266D1 (de) 1992-02-13

Family

ID=10590309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686117453T Expired - Fee Related DE3683266D1 (de) 1985-12-30 1986-12-15 Antibiotikum a 40926 mannosyl aglycon.

Country Status (14)

Country Link
US (1) US4782042A (de)
EP (1) EP0228015B1 (de)
JP (1) JP2514942B2 (de)
KR (2) KR950010460B1 (de)
AT (1) ATE71113T1 (de)
DE (1) DE3683266D1 (de)
DK (1) DK167815B1 (de)
ES (1) ES2038593T3 (de)
GB (1) GB8531846D0 (de)
GR (1) GR3003514T3 (de)
HU (1) HU201099B (de)
IE (1) IE59603B1 (de)
IL (1) IL81105A (de)
ZA (1) ZA869716B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK363587A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
GR871488B (en) * 1986-10-10 1987-11-12 Lepetit Spa New antibiotics
EP0376042B1 (de) * 1988-12-27 1996-03-13 GRUPPO LEPETIT S.p.A. Chemisches Verfahren zur Herstellung des Antibiotikums L 17392 (Deglukoteicoplanin) und dessen Salze
US5206834A (en) * 1989-10-14 1993-04-27 Mitsubishi Denki Kabushiki Kaisha Semiconductor memory device performing last in-first out operation and the method for controlling the same
DE69012942T2 (de) * 1989-10-16 1995-03-02 Lilly Co Eli Glycopeptid-Antibiotika.
US5224972A (en) * 1990-09-11 1993-07-06 Frye Gregory C Coatings with controlled porosity and chemical properties
EP0560795B1 (de) * 1990-12-05 1996-02-21 GRUPPO LEPETIT S.p.A. 38-decarboxy-38-hydroxymethylderivate von teicoplaninantibiotika, und verfahren zu deren herstellung
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
EP0578644B1 (de) 1991-03-27 1996-12-04 GRUPPO LEPETIT S.p.A. Esterderivate von antibiotikum-a 40926
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
CN1036654C (zh) * 1993-01-01 1997-12-10 格鲁波莱佩蒂特公司 抗菌素a40926的酰氨衍生物及其制备方法
DK0836619T3 (da) * 1995-07-05 2004-12-06 Aventis Bulk S P A Oprensning af dalbaheptid antibiotika ved hjælp af isoelektrisk fokusering
DK0912604T3 (da) 1996-04-23 2002-03-25 Biosearch Italia Spa Forbedret kemisk fremgangsmåde til fremstilling af amidderivater af A 40926 antibiotikum
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP1565201B1 (de) * 2002-11-18 2018-10-31 Vicuron Pharmaceuticals, Inc. Methoden zur verabreichung von dalbavancin zur behandung bakterieller infektionen
JP5852880B2 (ja) * 2011-12-28 2016-02-03 国立研究開発法人国立循環器病研究センター 温度感応性材料
US20220204551A1 (en) * 2019-04-30 2022-06-30 Huvepharma Italia S.R.L. Method for the purification of lipoglycopeptide antibiotics
KR102467772B1 (ko) 2022-08-23 2022-11-16 최세근 디자인에 따라 결합 가능한 모듈이 구비된 신발

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521335A (en) * 1983-07-13 1985-06-04 Smithkline Beckman Corporation Aglycone and pseudo-aglycones of the AAD 216 antibiotics
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex

Also Published As

Publication number Publication date
DK617086D0 (da) 1986-12-19
KR960010556B1 (ko) 1996-08-02
ES2038593T3 (es) 1993-08-01
IL81105A0 (en) 1987-03-31
IE59603B1 (en) 1994-03-09
HU201099B (en) 1990-09-28
DK167815B1 (da) 1993-12-20
KR950010460B1 (ko) 1995-09-18
EP0228015A3 (en) 1987-12-16
ZA869716B (en) 1987-10-28
HUT43091A (en) 1987-09-28
EP0228015B1 (de) 1992-01-02
JP2514942B2 (ja) 1996-07-10
US4782042A (en) 1988-11-01
IE863381L (en) 1987-06-30
KR870006193A (ko) 1987-07-09
GR3003514T3 (de) 1993-03-16
ATE71113T1 (de) 1992-01-15
DK617086A (da) 1987-07-01
EP0228015A2 (de) 1987-07-08
JPS62175499A (ja) 1987-08-01
GB8531846D0 (en) 1986-02-05
KR890002230A (ko) 1989-04-08
IL81105A (en) 1991-09-16

Similar Documents

Publication Publication Date Title
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
MY101178A (en) Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon
DK312688A (da) Glykkopeptid-antibiotika
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
ATE144780T1 (de) Megakaryocytopoietischer faktor
ES8202561A1 (es) Un procedimiento para la produccion de 11,12-carbonato de eritromicilamina
DE3872916D1 (de) Herstellung und reinigung eines n,n-diethylaminophenols.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee